Skip to main content
logo
Imugene Limited (ASX:IMU)
Australia flag Australia · Delayed Price · Currency is AUD
0.3650
-0.0250 (-6.41%)
Oct 28, 2025, 4:10 PM AEST

Imugene Revenue

In the fiscal year ending June 30, 2025, Imugene had annual revenue of 4.40M AUD, down -11.53%. Imugene had revenue of 3.14M in the half year ending June 30, 2025, a decrease of -54.94%.

Revenue
4.40M
Revenue Growth
-11.53%
P/S Ratio
26.24
Revenue / Employee
879.36K
Employees
5
Market Cap
115.37M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20254.40M-573.22K-11.53%
Jun 30, 20244.97M-6.81M-57.80%
Jun 30, 202311.78M-1.19M-9.19%
Jun 30, 202212.97M5.74M79.35%
Jun 30, 20217.23M3.10M74.94%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.73B
Ramsay Health Care17.79B
Sonic Healthcare9.65B
Ansell3.06B
Cochlear2.34B
Regis Healthcare1.16B
Telix Pharmaceuticals1.01B
Neuren Pharmaceuticals218.86M
Revenue Rankings

Imugene News

More News